ArticleGenomics, proteomics & bioinformatics2025
Deep Transfer Learning Links Benign Glands to Prostate Cancer Progression via Transcriptomics.
Article in Genomics, proteomics & bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The field effect describes the phenomena where environmental exposures, infection, and genetic predisposition result in molecular changes in cells that predispose them to developing cancer. Though this is a well-established concept in pathology, it remains underexplored in the context of high-resolution omics. We utilized the Diagnostic Evidence Gauge of Single Cells (DEGAS) deep transfer learning framework to analyze prostate cancer spatial transcriptomics to identify cells and tissues that are highly associated with cancer progression. DEGAS highlighted morphologically benign glands with reduced expression of microseminoprotein-beta (MSMB), a differentiation marker downregulated in aggressive tumors. These glands have upregulated genes associated with antigen presentation and aggressive neoplasms. Integration of single-cell transcriptomics and deep learning image analysis separately revealed altered immune-cell infiltration, suggesting a complex interplay in the tumor environment, facilitating aggressiveness. We used immunohistochemistry to quantify the MSMB protein (PSP-94) expression in morphologically normal and tumor tissues from patients with and without 5-year distant metastasis. Samples from patients who developed metastasis consistently showed lower fractions of positively stained cells, indicating a subtle yet significant "field effect" in seemingly benign regions. These proteomic results validate the transcriptomic findings and further underscore that inflammatory or immune-related changes in ostensibly normal tissue may contribute to aggressive disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.